Higgins T N, Blakney G B, Dayton J
Dynacare Kasper Medical Laboratories, T5V 1B4, Edmonton, Alberta, Canada.
Clin Biochem. 2001 Jul;34(5):361-5. doi: 10.1016/s0009-9120(01)00229-6.
To evaluate the analytical performance of the Bio-Rad Variant II HbA(1C) analyzer (a completely automated system for the quantification of glycohemoglobin [HbA(1C)] in blood).
The analytical parameters of precision, linearity and analytical range were assessed and HbA(1C) results from the Variant II were compared to HbA(1C) results from the Bio-Rad Variant (a method certified by the National Glycohemoglobin Standardization Program). The effect of a variety of hemoglobin variants on HbA(1C) obtained on the system was investigated.
Total imprecision was less than 5% and the results compared well with those from an established method. The method has a wide analytical range with no carryover between specimens.
The HbA(1C) method on the Variant II gives acceptable analytical performance.
评估伯乐Variant II HbA(1C)分析仪(一种用于定量血液中糖化血红蛋白[HbA(1C)]的全自动系统)的分析性能。
评估精密度、线性和分析范围等分析参数,并将Variant II的HbA(1C)结果与伯乐Variant(一种经国家糖化血红蛋白标准化计划认证的方法)的HbA(1C)结果进行比较。研究了多种血红蛋白变体对该系统所测HbA(1C)的影响。
总不精密度小于5%,结果与既定方法的结果比较良好。该方法具有较宽的分析范围,且标本之间无残留。
Variant II上的HbA(1C)方法具有可接受的分析性能。